Evidence map›Paper›PMID 26347516›Full record

ArticleGut and liver2016

Gastroprotective Effects of PMK-S005 against Ethanol-Induced Acute Gastric Damage in Rats.

Yoon Jeong Choi, Nayoung Kim, Ju Yup Lee, Ryoung Hee Nam, Ji Hyung Seo, Seonmin Lee, Hee Jin Kim, Yoon Jin Choi, Hye Seung Lee, Dong Ho Lee

Abstract read
In one paragraph

Article in Gut and liver, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Gastroprotective Effects ofInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Yoon Jeong ChoiDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Nayoung KimDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Ju Yup LeeDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Ryoung Hee NamDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Ji Hyung SeoDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Seonmin LeeDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Hee Jin KimDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Yoon Jin ChoiDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Hye Seung LeeDepartment of Pathology, Seoul National University Bundang Hospital, Seongnam, Korea.
Dong Ho LeeDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsThis study aimed to examine the gastroprotective effects of PMK-S005, which is a synthetic S-allyl-Lcysteine (SAC; a sulfur-containing amino acid), against acute ethanol-induced gastric damage in rats.

methodsSprague- Dawley rats were divided into six groups, including a nonethanol group, groups treated with absolute ethanol 1 hour after pretreatment with various doses of PMK-S005 (1, 5, and 10 mg/kg) or rebamipide (50 mg/kg), and an absolute ethanolonly group. Ethanol-induced gross ulcer and mucus levels were measured. Myeloperoxidase, tumor necrosis factor a, interleukin 1β, PGE₂, LTB₄, cPLA₂, COX-1, and COX-2 levels were estimated by enzyme-linked immunosorbent assay or Western blot analysis. Furthermore, the protein expression levels of antioxidant enzymes, including heme oxygenase-1 (HO-1), NAD(P)Hquinine oxidoreductase 1 (NQO-1), GCLC, and GCLM, were assessed.

resultsPMK-S005 significantly attenuated the ethanol-induced gastric damage; it reduced mucosal inflammatory cytokine production and increased mucus levels. The expression levels of cPLA₂, COX-1, and COX-2 were decreased by PMK-S005. PMK-S005 did not affect PGE₂ synthesis, but LTB₄ production was significantly suppressed. In addition, long-term administration of PMKS005 significantly increased the expression of HO-1, NQO-1, GCLC, and GCLM.

conclusionsThese results strongly suggest that PMK-S005 prevents gastric mucosal damage and that these gastroprotective activities are due to anti-inflammatory effects and enhancement of the gastric defense system, including antioxidant enzymes.

Indexed as

AnimalsAnti-Inflammatory AgentsAntioxidantsBlotting, WesternCyclooxygenase 1Cyclooxygenase 2Enzyme-Linked Immunosorbent AssayEthanolGastric MucosaGastritisGastrointestinal AgentsHexosaminesInterleukin-1betaIrritantsMalePeroxidaseAnti-Inflammatory AgentsAntioxidantsCyclooxygenase 1Cyclooxygenase 2EthanolGastrointestinal AgentsHexosaminesInterleukin-1betaIrritantsPeroxidasePhospholipases A2, CytosolicPlant ExtractsPMK-S005Tumor Necrosis Factor-alphaAnti-inflammationAntioxidantsEthanolGastroprotectionS-allyl-L-cysteine

Identifiers

PMID26347516
PMCPMC4849686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.